John Stamos will receive the Bob Saget Legacy Award for his longtime support of scleroderma research at an October SRF fundraiser. sclerodermanews.com/news/joh…
Treatment guidelines for systemic scleroderma (SSc) have evolved with advances in scientific understanding, a study shows. sclerodermanews.com/news/stu…
Blood protein KL-6 may help identify people with SSc-ILD at greater risk of short-term lung function decline. sclerodermanews.com/news/blo…
People with SSc who don’t show the scleroderma pattern of small blood vessel damage may have a milder course of the disease, per a study. sclerodermanews.com/news/lac…
A wireless sensor may help track scleroderma-related skin stiffness at home, but larger studies are needed to validate its use. sclerodermanews.com/news/wir…
A new scleroderma survey seeks patient experiences from adults to better understand disease burden, unmet needs, and research priorities. sclerodermanews.com/news/scl…
Off-label treatment with JAK inhibitors appeared to keep lung function stable in systemic sclerosis, according to a real-world-study. sclerodermanews.com/news/jak…
To mark awareness month and educate others this June, the National Scleroderma Foundation has launched a campaign dubbed "Beacons of Hope." buff.ly/b9ndqVc
The experimental scleroderma therapy BLR-200 showed promise in a mouse model to prevent the disease’s characteristic tissue scarring. buff.ly/RZPPV5S
Researchers have identified a molecular pathway in skin cells that may be involved in inflammation and scarring in scleroderma, per a study. buff.ly/wc9lGLk
Sex-specific genetic findings may offer clues into why systemic sclerosis affects women and men differently, a new study suggests. buff.ly/XA4A01p
In SSc without overlap syndrome, specific autoantibodies were tied to symptoms, while non-specific antibodies showed limited clinical value. sclerodermanews.com/news/aut…
Blood levels of the liver enzyme ALT are the most accurate predictor of AIH in people with systemic sclerosis, a study in Turkey shows. buff.ly/Urs9Iqn
Autologous stem cell transplant was effective for controlling scleroderma in a teenager with severe disease. buff.ly/Z49n67c
A genetic analysis identified existing medications that could be repurposed as potential scleroderma treatment options, a new study reports. sclerodermanews.com/news/stu…
Levels of anti-CD146 antibodies may help identify SSc associated with occupational exposure to silica and other mineral dusts, a study found. buff.ly/gcARnGm
The scleroderma drug AISA-021 safely reduced Raynaud’s attack frequency and duration in a study but still failed to meet its primary goal. buff.ly/G4Hbr3S
Hand baths enriched with carbon dioxide were found to ease symptoms of systemic sclerosis-associated Raynaud’s phenomenon in a small trial. buff.ly/TTuOCHp
SSc-ILD treatment use has increased over time, with registry data showing fewer lung disease progression events. buff.ly/BwJXcvl
Soluble CD13 levels are elevated in people with scleroderma, but may not reflect disease severity, a study finds. buff.ly/6Qv9JpE




















